Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)Tools Steger, GG, Greil, R, Lang, A, Rudas, M, Fitzal, F, Mlineritsch, B, Hartmann, BL, Bartsch, R, Melbinger, E, Hubalek, M, Stöger, H, Dubsky, P, Ressler, S, Petzer, AL, Singer, CF, Muss, C, Jakesz, R, Gampenrieder, SP, Zielinski, CC, Fesl, C and Gnant, M (2014) Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Ann Oncol.. Full text not available from this repository.
|
||||||||||||||||
|
|
|
Tools
Tools
